Proteomics International Laboratories Ltd (ASX:PIQ) is pleased to announce results showing a significant reduction in the PromarkerD risk scores of patients with type 2 diabetes after taking the diabetes medicine canagliflozin.
SYDNEY, Aug. 11, 2021 /PRNewswire/ Ascensia Diabetes Care, a global diabetes company has today disclosed data at the virtual Australasian Diabetes Conference (ADC) 2021, which takes place